MetaCap

DexCom Inc. (DXCM)

NASDAQ: DXCMHealth CareMedical/Dental InstrumentsUSD

79.32-0.87 (-1.08%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

DXCM stock chart

Technical analysis

Key statistics

All statistics
Market cap
$29.58B
52-week range
56.72 – 92.59
Day range
78.75 – 81.58
Volume / Avg
4.61M / 4.19M
Beta
—

52-week range

$56.72$92.59

DXCM stock today

Shares of DexCom (DXCM) finished lower on Nov 20 at $79.32, a drop of 1.08% or $0.87 per share, versus the S&P 500's 3.70% decline. At this level, DXCM sits in the middle of its 52-week range of $56.72 to $92.59: 14.3% below the high, set on Aug 24, 2026 and 39.8% above the low. DXCM is up 19.5% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 31.7%.

At 31.2x trailing earnings, DexCom trades below the peer-group median of 62.1x. Its forward P/E of 25.3x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year.

Summary generated from market data by MetaCap's automated system. Methodology

About DexCom

Company profile

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Day, an integrated continuous glucose monitoring system; Dexcom G6, a CGM system; Dexcom ONE+ to replace fingerstick blood glucose testing for diabetes treatment decisions; Stelo, a biosensor designed for adults with prediabetes and Type 2 diabetes who do not use insulin; Dexcom Share, a remote monitoring system; and Dexcom Follow application. It markets its products directly to endocrinologists, physicians, and diabetes educators.

Industry
Medical/Dental Instruments
CEO
Mr. Jacob Steven Leach
Headquarters
San Diego, CA
Employees
11,000
IPO year
2005
Website
dexcom.com

Financial highlights

Full financials

In fiscal 2025, DexCom generated $4.66 billion in revenue, up 15.6% from fiscal 2024, its 16th consecutive year of revenue growth. Net income was $836.3 million (+45.1% year over year), for a net margin of 17.9% versus a median of 14.3% in the prior 5 years. Gross margin was 60.1% (down from 60.5%) and operating margin 19.6%.

DexCom annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$4.66B$4.03B$3.62B$2.91B$2.45B
Growth+15.60%+11.34%+24.49%+18.84%+27.08%
Net income$836.30M$576.20M$541.50M$341.20M$216.90M
EPS (diluted)$2.09$1.42$1.30$0.82$0.53

Analyst forecast

Forecast

Consensus (29 analysts)

strong_buy

Avg. price target

$98.58+24.28%

  • Strong buy 4
  • Buy 22
  • Hold 3
  • Sell 0
  • Strong sell 0

Target range

Low $79.00High $120.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Oct 29, 2026
EPS actual vs est.
$0.72 vs $0.66
Surprise
+9.09%

DXCM news

All DXCM news

DexCom peers

Health Care sector
DXCM peer companies
CompanyPrice% ChgMarket capCompare
WSTWest Pharmaceutical Services Inc.390.30-1.61%$27.19Bvs DXCM
RMDResMed Inc.235.63-0.53%$33.14Bvs DXCM
SOLVSolventum Corporation84.50-1.52%$14.36Bvs DXCM
GKOSGlaukos Corporation237.31-0.33%$14.05Bvs DXCM
BAXBaxter International Inc.25.390.00%$13.14Bvs DXCM
PENPenumbra Inc.319.12-0.28%$12.58Bvs DXCM
MDLNMedline Inc. Class A37.04-2.11%$48.75Bvs DXCM
PODDInsulet Corporation133.17-2.96%$9.24Bvs DXCM

Indexes, lists and sector

DexCom stock FAQ

What is DexCom's stock price today?

DXCM last traded at $79.32 as of Nov 20, 4:00 PM EST, down 1.08% on the day. Prices are delayed at least 15 minutes.

Does DexCom pay a dividend?

No. DexCom does not currently pay a regular cash dividend.

What is DXCM's P/E ratio?

DXCM trades at a trailing P/E ratio of 31.23 and a forward P/E of 25.30, compared with a median of 62.1 for its closest peers.

Is DexCom in the S&P 500?

Yes. DexCom (DXCM) is a constituent of the S&P 500 index.

Who is DexCom's CEO?

Mr. Jacob Steven Leach is the chief executive officer of DexCom Inc., which has about 11,000 employees.

Has DXCM ever split its stock?

Yes. The most recent DXCM stock split was a 4-for-1 split on Jun 13, 2022.

What is the DXCM 52-week high?

The 52-week high for DXCM is $92.59 and the 52-week low is $56.72. The stock is currently 14.3% below its high.

Compare DXCM